SlideShare ist ein Scribd-Unternehmen logo
1 von 42
Downloaden Sie, um offline zu lesen
Presented by,
Anvita Jadhav
M.Pharm (IP) Sem I
What is Quality
 It can be defined in different ways
 Conformance to specifications measures how well the product or
service meets the targets and tolerances determined by its designers.
 Fitness for use focuses on how well the product performs its
intended function or use.
 Value for price paid is a definition of quality that consumers often
use for product or service usefulness.
 Support services provided are often how the quality of a product or
service is judged.
 A psychological criterion is a subjective definition that focuses on the
judgmental evaluation of what constitutes product or service quality.
Dimensions of Quality
Performance
Features
Reliability
Conformance
Durability
Serviceability
Aesthetics
Perceived quality
Difference between Pharmaceutical Product &
Consumer Goods
Pharmaceutical Product Consumer Goods
Development
• 2 – 3 years
Payer
• Customer
Regulation
• Low level of regulation
Development
• 10 – 15 years
Payer
• Mostly patient
Regulation
• Highly regulated
Sterile Product
 These products are by design required to be
free from living micro organisms, pyrogens,
& unacceptable particulate matter.
 Therefore it has more regulations than non
sterile product
 In addition to non sterile product quality
guidelines there are other procedures such as
– Sterilization, Aseptic processing and also
Premises Regulations, Equipments etc.
Guidelines of the Pharmaceutical Quality
WHO Guidelines
FDA Guidelines
ICH Guidelines
Quality
System
Facilities &
Equipment
System
Laboratory
Control
System
Packaging
&
Labeling
System
Production
System
Material
System
Facilities & Equipment
 Equipment must be located, designed, constructed, adapted,
and maintained to suit the operations to be carried out.
 Guidelines given by
 WHO Volume 2: good manufacturing practices and inspection
(Quality Assurance of Pharmaceuticals), 13.1 to 13.13
 US FDA: 21 CFR Part 211.63, 211.105, 211. 68, 211.72,
211.182
 Schedule M: 11.1 – 11.5
Material
 The main objective of a pharmaceutical plant is to produce
finished products for patients use from a combination of
materials (starting and packaging).
 Guidelines given by
 WHO Volume 2: good manufacturing practices and
inspection (Quality Assurance of Pharmaceuticals) 14.1 to
14.46
 US FDA: 21 CFR Part 211
 Schedule M: 10.1 – 10.10, 13.1 -13.6,
Production
 Production operations must follow clearly defined
procedures in accordance with manufacturing and marketing
authorizations, with the objective of obtaining products of the
requisite quality.
 Guidelines given by
 WHO Volume 2: good manufacturing practices and
inspection (Quality Assurance of Pharmaceuticals) 16.1 to
16.35
 US FDA: 21 CFR Part 211
 Schedule M: 8.1, 8.2, 9.1 – 9.5, 10.2, 24.1 – 24.3
Packaging & labeling
 All operations, including filling and labeling, that
a bulk product has to undergo in order to become
a finished product.
 Labels applied to containers, equipment or
premises should be clear, unambiguous and in
the company’s agreed format.
 Guidelines given by
 WHO Volume 2: good manufacturing practices
and inspection (Quality Assurance of
Pharmaceuticals)
 US FDA: 21 CFR Part 211
Laboratory Controls
 It is concerned with the organizational process
and the conditions under which laboratory
studies are planned, performed, monitored,
recorded, and reported.
 Guidelines given by:
 FDA: 21 CFR 58
 WHO: handbook of GLP
Clinical Practices
 Various regulations are involved clinical trials involving
human subjects. Guidelines include protection of human
rights as a subject in clinical trial. It also provides assurance
of the safety and efficacy of the newly developed
compounds.
 Guidelines given by
 WHO: Handbook for Good clinical practice
 ICH guidelines
 Schedule Y
General Practices Recently Applied in the
Pharmaceutical Industry
Quality risk
management
Quality by design
Corrective action and
preventive actions
Total quality
management
 The basic meaning focuses on target
populations of regulation, the extent to
which they comply with regulation, and
why they do so.
Compliance
Fulfillment/
Conformity
Compliance encourages-
Ethical behavior
Fosters the right values
Instills a culture of integrity
Regulatory Compliance
 The regulatory authorities are empowered to
issue and enforce regulations for the
manufacture of pharmaceutical products .
 Individual pharmaceutical companies produce
a set of internal guidelines, rules, and policies
to implement the regulation imposed by the
regulatory authorities.
 Regulatory compliance applied to statements
Compliance Program
to review policies & procedures through
which industry complies with the various
regulations
program to prevent & detect violations of
the regulation.
Strategies to achieve
Compliance
1
• Creating an Environment that Supports Compliance
2
• Making Compliance Part of Everyone's Job.
3
• Empowering the Regulatory Affairs/Quality Assurance Function
4
• Employ the Appropriate Skills to Obtain Cooperation
5
• Educating Other Departments.
6
• Selling the Benefits of Quality and Compliance.
7
• Using Internal Audits Effectively.
8
• Reviewing and Reporting Quality and Compliance Data.
9
• Explaining the Consequences of Noncompliance.
Quality Policies
 The ISO 9000 requires quality policies to ensure
that executive management has established system
for quality.
 Quality policies define numerous systems as well
as executive management’s commitment to
quality.
Purpose & intent of quality
policies
 Quality policies help industries to improve their
internal compliance & total quality system.
 By instituting & adhering to quality policies,
management obtains employees commitment to quality
system.
 The formulation of individual quality policies should
include the involved groups, depending on the
placement of responsibilities within the individual
organization.
Format & content of individual quality policies
 Executive management will probably determine who writes & edits the
individual quality policies.
 Policies should contain minimal information on specific procedure &
detailed information about structure, responsibility, & review.
 Definitions within policies are important to ensure that all parties are
speaking the same language & are understanding.
 The policy should define the responsibilities of individual department
implementing the policy & should ensure that adequate resources &
structure exist for successful implementation.
Validation
 Pharmaceutical validation can be defined as a
documented program, which provides a high
degree of assurance that a specific process will
consistently produce, a product meeting its pre-
determined specifications & quality attributes
Advantages of validation
Reduction of quality costs
Process optimization
Assurance of quality
Safety
CAPA – Compliance Tool
 CAPA is corrective and preventive action
 Corrective action: Action to eliminate the cause of
a detected nonconformity or other undesirable
situation.
 Preventive action: Action to eliminate the cause of
a potential nonconformity or other undesirable
potential situation.
CAPA Process
 Identification
 Impact / Risk Assessment
 Immediate Action
 Root Cause Investigation
 Conclusion and Quality Decision
 Action Plan
 Implementation and Follow-up
Documentation
 Document is a piece of written, typed,
printed or electronic matter that provides
information or evidence.
 In each case, key sections of the documents
are examined for compliance.
Documentation is essential-
 To define the specifications/procedures for all materials and methods of
manufacture control.
 To ensure that all personnel concerned with manufacturing know what to
do and when to do it.
 To ensure that authorized persons have all the information necessary to
decide whether or not to release a batch of a drug for sale.
 To ensure the existence of documented evidence, traceability and to
provide records and an audit trail that will permit investigation.
 To ensure the availability of the data needed for validation, review and
statistical analysis.
Categories of documents
 Specification (e.g. raw material, packaging material,
intermediate, finished product)
 Procedures (e.g. SOPs, STPs, process packaging instruction)
 Records & Reports
 Master Documents (e.g. MPCR, calibration master plan, site
master file etc.)
 Lists (e.g. certified vendors, employees, equipment, process
rooms)
Cost of Quality Compliance
Cost of Quality Compliance
Quality control
costs
Prevention costs
Costs of preparing and
implementing a quality
plan.
Appraisal costs
Costs of testing, evaluating,
and inspecting quality
Quality failure costs
Internal failure costs
Costs of scrap, rework,
and material losses.
External failure costs
Costs of failure at customer site,
including returns, repairs, and
recalls.
Effects of non compliance
 Complaints & adverse effects: Complaints about product is
an indicator of the product quality, & also about the
expectation of the consumer from the product.
 Recall of the product: A distributed product can be called
back for various reasons. Manufacturer or FDA officials found
out that the product is substandard.
Case Study
 The U.S. Food and Drug Administration had notified
(on 23/1/2014) Ranbaxy Laboratories, Ltd., that it is
prohibited from manufacturing and distributing
active pharmaceutical ingredients (APIs) from its
facility in Toansa, India, for FDA-regulated drug
products.
 The FDA’s inspection on Jan. 11, 2014, identified
significant CGMP violations. These included Toansa
staff retesting raw materials, intermediate drug
products, and finished API after those items failed
analytical testing and specifications, in order to
produce acceptable findings, and subsequently not
reporting or investigating these failures.
Reasons for Non compliance
1. Lack of Regulatory Knowledge
 Requirements are too complex to know and
understand.
 People cannot comply with regulations if
they do not understand what is required.
2 Lack of willingness towards compliance
 Compliance is too costly
 Overly legalistic regulation
 Failure to monitor
 Deterrence failure.
3. Lack of ability to achieve compliance
 Failures of administrative capacity
 Desired outcomes cannot be achieved
Quality Audit
 Auditors are typical part of regulatory
compliance for examine the data trail to
determine whether company policies and
procedures are followed.
 It has different categories –
1) Internal audits
2) External audits
3) Regulatory audits
Percentage of compliance:
 100% compliance: When the auditor is fully satisfied with
the compliance by the auditee by conforming that the auditee
meets all the requirements specified in the specific clause
 100% non compliance: When the auditor finds the
requirements of the specific clause in not all complied with by
the auditee.
 Partial compliance: When the auditor finds that the auditee
has not fully compiled but only part compliance is observed.
Compliance classifications (according to
US FDA)
 NAI – (No Action Indication)
No objectionable conditions or practices were found
during the inspection
 VAI – (Voluntary Actions Indicated)
Objectionable conditions were found and documented
but objectionable conditions do not meet the threshold
for regulatory action
 OAI – (Official FDA Action Indicated)
Regulatory violence is observed
Conclusion
Quality & safety should be priority of any
pharmaceutical industry.
Quality can be achieved by the compliance
excellence with the regulations.
Compliance program should be there to study
regulation & to implement them in best manner.
It is the responsibility of everyone.
Reference:
 Bhaskar Mazumder, Sanjib Bhattacharya and Abhishek Yadav, Total Quality
Management in Pharmaceuticals: A Review, International Journal of PharmTech
Research, Vol.3, No.1, Pg. No. 365-375, Jan-Mar 2011.
 Sumit Kumar, Deepika Tanwar, Nageen Arora, The Role of Regulatory GMP Audit in
Pharmaceutical Companies, International Journal of Research and Development in
Pharmacy and Life Sciences, Vol. 2, No.4, Pg. No. 493-498, June - July, 2013.
 Reham M. Haleem, Maissa Y. Salem, Faten A. Fatahallah, Laila E. Abdelfattah, Quality in
the Pharmaceutical Industry – A Literature Review, Saudi Pharmaceutical Journal, 2014.
 Julie Fishera, Arantza Aldeaa, René Banares-Alcantara, A Compliance Management
System for the Pharmaceutical Industry, 18th European Symposium on Computer Aided
Process Engineering – ESCAPE 18, 2008.
 Achieving Quality and Compliance Excellence in Pharmaceuticals, Editor Madhu Raju
Saghee, Business Horizons, 2012.
 U.S. Pharmaceuticals, Compliance and Ethics Code of Conduct, Bristol-Myers Squibb
Company, January 1, 2009.
 Nancy Singer and Richard DeRisio, Optimizing Regulatory Compliance: Nine Strategies for
Success, Compliance-Alliance LLC and Kinetic Concepts Inc., Medical Device and Diagnostic
Industry, 2005.
 Chapter 2 Compliance Failures, Reducing the Risk of Policy Failure: Challenges for Regulatory
Compliance, Organization for Economic Co-operation and Development, 2000.
 Ms. Marlise Gyger, CAPA (Corrective Actions and Preventive Actions), Quality and GMP, June
2012.
 James E. Carter, Quality Policies – Key to GMP compliance, Pharmaceutical Technology,
October 1998.
 http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm382736.htm
 Quality Assurance of Pharmaceuticals, Good Manufacturing Practices & Inspection, World
Health Organization, Volume 2, Second Edition, 2007.
 Manohar A. Potdar, cGMP for Pharmaceuticals, PharmMed Press, 2012.
Quality & compliance excellence in pharmaceuticals

Más contenido relacionado

Was ist angesagt?

Good Automated Manufacturing Practices
Good Automated Manufacturing PracticesGood Automated Manufacturing Practices
Good Automated Manufacturing PracticesPrashant Tomar
 
Good Automated Laboratory Practices
Good Automated Laboratory PracticesGood Automated Laboratory Practices
Good Automated Laboratory PracticesSwapnil Fernandes
 
Gmp (good manufacturing practices)
Gmp (good manufacturing practices)Gmp (good manufacturing practices)
Gmp (good manufacturing practices)RAJESHWAR CHAVAN
 
Validation master plan
Validation master planValidation master plan
Validation master planDr. Amsavel A
 
BMR (Batch Manufacturing Record)
BMR (Batch Manufacturing Record)BMR (Batch Manufacturing Record)
BMR (Batch Manufacturing Record)Ram Mohan S R
 
Master batch record,batch production record ,Quality Audit Type and plan &Rec...
Master batch record,batch production record ,Quality Audit Type and plan &Rec...Master batch record,batch production record ,Quality Audit Type and plan &Rec...
Master batch record,batch production record ,Quality Audit Type and plan &Rec...KarishmaFuse
 
Distribution, Electronic data handling and controlled documentation by Khushb...
Distribution, Electronic data handling and controlled documentation by Khushb...Distribution, Electronic data handling and controlled documentation by Khushb...
Distribution, Electronic data handling and controlled documentation by Khushb...KhushbooKunkulol
 
Sanitation in Manufacturing Premises
Sanitation in Manufacturing Premises Sanitation in Manufacturing Premises
Sanitation in Manufacturing Premises GNIPST
 
WHO GMP Requirements
WHO GMP  RequirementsWHO GMP  Requirements
WHO GMP RequirementsDeekshitha HS
 
Pharmaceutical Packaging
Pharmaceutical PackagingPharmaceutical Packaging
Pharmaceutical Packagingrishitiwari42
 
Good Documentation Practice (GDP)
Good Documentation Practice (GDP)Good Documentation Practice (GDP)
Good Documentation Practice (GDP)Hossen M. Faruk
 
Time limitation on production
Time limitation on productionTime limitation on production
Time limitation on productionDhruvi50
 
NEW ERA OF DRUG PRODUCT: OPPORTUNITIES AND CHALLENGES
NEW ERA OF DRUG PRODUCT: OPPORTUNITIES AND CHALLENGESNEW ERA OF DRUG PRODUCT: OPPORTUNITIES AND CHALLENGES
NEW ERA OF DRUG PRODUCT: OPPORTUNITIES AND CHALLENGESganpat420
 
paharmaceutical packaging Medical device Packaging types of medical device p...
paharmaceutical packaging Medical device Packaging  types of medical device p...paharmaceutical packaging Medical device Packaging  types of medical device p...
paharmaceutical packaging Medical device Packaging types of medical device p...RavichandraNadagouda
 

Was ist angesagt? (20)

Good Automated Manufacturing Practices
Good Automated Manufacturing PracticesGood Automated Manufacturing Practices
Good Automated Manufacturing Practices
 
Good Automated Laboratory Practices
Good Automated Laboratory PracticesGood Automated Laboratory Practices
Good Automated Laboratory Practices
 
Gmp (good manufacturing practices)
Gmp (good manufacturing practices)Gmp (good manufacturing practices)
Gmp (good manufacturing practices)
 
Doc in pharma
Doc in pharmaDoc in pharma
Doc in pharma
 
Validation master plan
Validation master planValidation master plan
Validation master plan
 
BMR (Batch Manufacturing Record)
BMR (Batch Manufacturing Record)BMR (Batch Manufacturing Record)
BMR (Batch Manufacturing Record)
 
Good Distribution Practices
Good Distribution PracticesGood Distribution Practices
Good Distribution Practices
 
Master batch record,batch production record ,Quality Audit Type and plan &Rec...
Master batch record,batch production record ,Quality Audit Type and plan &Rec...Master batch record,batch production record ,Quality Audit Type and plan &Rec...
Master batch record,batch production record ,Quality Audit Type and plan &Rec...
 
Distribution, Electronic data handling and controlled documentation by Khushb...
Distribution, Electronic data handling and controlled documentation by Khushb...Distribution, Electronic data handling and controlled documentation by Khushb...
Distribution, Electronic data handling and controlled documentation by Khushb...
 
Sanitation in Manufacturing Premises
Sanitation in Manufacturing Premises Sanitation in Manufacturing Premises
Sanitation in Manufacturing Premises
 
WHO GMP Requirements
WHO GMP  RequirementsWHO GMP  Requirements
WHO GMP Requirements
 
7.specification and test procedure
7.specification and test procedure 7.specification and test procedure
7.specification and test procedure
 
Pharmaceutical Packaging
Pharmaceutical PackagingPharmaceutical Packaging
Pharmaceutical Packaging
 
Good Documentation Practice (GDP)
Good Documentation Practice (GDP)Good Documentation Practice (GDP)
Good Documentation Practice (GDP)
 
Time limitation on production
Time limitation on productionTime limitation on production
Time limitation on production
 
NEW ERA OF DRUG PRODUCT: OPPORTUNITIES AND CHALLENGES
NEW ERA OF DRUG PRODUCT: OPPORTUNITIES AND CHALLENGESNEW ERA OF DRUG PRODUCT: OPPORTUNITIES AND CHALLENGES
NEW ERA OF DRUG PRODUCT: OPPORTUNITIES AND CHALLENGES
 
1.c gmp as per schedule m
1.c gmp as per schedule m 1.c gmp as per schedule m
1.c gmp as per schedule m
 
paharmaceutical packaging Medical device Packaging types of medical device p...
paharmaceutical packaging Medical device Packaging  types of medical device p...paharmaceutical packaging Medical device Packaging  types of medical device p...
paharmaceutical packaging Medical device Packaging types of medical device p...
 
QUALITY ASSURANCE
QUALITY ASSURANCEQUALITY ASSURANCE
QUALITY ASSURANCE
 
Q6 guidelines
Q6 guidelinesQ6 guidelines
Q6 guidelines
 

Andere mochten auch

IND Application Process and Best Practices
IND Application Process and Best PracticesIND Application Process and Best Practices
IND Application Process and Best PracticesCFTCC
 
Good manufacturing practice (GMP)
Good manufacturing practice (GMP)Good manufacturing practice (GMP)
Good manufacturing practice (GMP)Sagar Savale
 
Quality Management Systems Potential LLC Brochure
Quality Management Systems Potential LLC BrochureQuality Management Systems Potential LLC Brochure
Quality Management Systems Potential LLC BrochureSteve Gompertz
 
Reg & Qa GMP
Reg & Qa GMPReg & Qa GMP
Reg & Qa GMPLouise666
 
INDs: When Required and Contents
INDs: When Required and ContentsINDs: When Required and Contents
INDs: When Required and ContentsLouise666
 
Quality management systems for medical, pharmaceutical,
Quality management systems for medical, pharmaceutical,Quality management systems for medical, pharmaceutical,
Quality management systems for medical, pharmaceutical,Khalizan Halid
 
Quality Management System of Coca-Cola
Quality Management System of Coca-ColaQuality Management System of Coca-Cola
Quality Management System of Coca-ColaTharushika Ruwangi
 
Quality Management Systems in different industries - from ISO 9001 to cGxP
Quality Management Systems in different industries - from ISO 9001 to cGxPQuality Management Systems in different industries - from ISO 9001 to cGxP
Quality Management Systems in different industries - from ISO 9001 to cGxPPauwels Consulting
 
Total quality management 1 .pps
Total quality management 1 .ppsTotal quality management 1 .pps
Total quality management 1 .ppsharshavardhanan
 
Total quality management (tqm)ادارة الجودة الشاملة
Total quality management (tqm)ادارة الجودة الشاملةTotal quality management (tqm)ادارة الجودة الشاملة
Total quality management (tqm)ادارة الجودة الشاملةIbrahim Alhariri
 

Andere mochten auch (12)

IND Application Process and Best Practices
IND Application Process and Best PracticesIND Application Process and Best Practices
IND Application Process and Best Practices
 
Supplier Selection
Supplier SelectionSupplier Selection
Supplier Selection
 
Good manufacturing practice (GMP)
Good manufacturing practice (GMP)Good manufacturing practice (GMP)
Good manufacturing practice (GMP)
 
Quality Management Systems Potential LLC Brochure
Quality Management Systems Potential LLC BrochureQuality Management Systems Potential LLC Brochure
Quality Management Systems Potential LLC Brochure
 
Quality Management Systems
Quality Management SystemsQuality Management Systems
Quality Management Systems
 
Reg & Qa GMP
Reg & Qa GMPReg & Qa GMP
Reg & Qa GMP
 
INDs: When Required and Contents
INDs: When Required and ContentsINDs: When Required and Contents
INDs: When Required and Contents
 
Quality management systems for medical, pharmaceutical,
Quality management systems for medical, pharmaceutical,Quality management systems for medical, pharmaceutical,
Quality management systems for medical, pharmaceutical,
 
Quality Management System of Coca-Cola
Quality Management System of Coca-ColaQuality Management System of Coca-Cola
Quality Management System of Coca-Cola
 
Quality Management Systems in different industries - from ISO 9001 to cGxP
Quality Management Systems in different industries - from ISO 9001 to cGxPQuality Management Systems in different industries - from ISO 9001 to cGxP
Quality Management Systems in different industries - from ISO 9001 to cGxP
 
Total quality management 1 .pps
Total quality management 1 .ppsTotal quality management 1 .pps
Total quality management 1 .pps
 
Total quality management (tqm)ادارة الجودة الشاملة
Total quality management (tqm)ادارة الجودة الشاملةTotal quality management (tqm)ادارة الجودة الشاملة
Total quality management (tqm)ادارة الجودة الشاملة
 

Ähnlich wie Quality & compliance excellence in pharmaceuticals

Basic concepts of QA and QC
Basic concepts of QA and QCBasic concepts of QA and QC
Basic concepts of QA and QCGargi Nanda
 
Lecture 2: QA and Qc in Pharma Industry
Lecture 2: QA and Qc in Pharma IndustryLecture 2: QA and Qc in Pharma Industry
Lecture 2: QA and Qc in Pharma IndustrySapan Shah
 
PharmaceuticalQuality by Design (QbD) An Introduction Process Development a...
PharmaceuticalQuality by Design (QbD)   An Introduction Process Development a...PharmaceuticalQuality by Design (QbD)   An Introduction Process Development a...
PharmaceuticalQuality by Design (QbD) An Introduction Process Development a...Bachu Sreekanth
 
Quality assurance tools & techniques
Quality assurance tools & techniquesQuality assurance tools & techniques
Quality assurance tools & techniquesPRANJAY PATIL
 
good laboratory practices.pptx
good laboratory practices.pptxgood laboratory practices.pptx
good laboratory practices.pptxssuserd2507a
 
Qa tools and techniques
Qa tools and techniquesQa tools and techniques
Qa tools and techniquesprashik shimpi
 
quality assurance.pptx
quality assurance.pptxquality assurance.pptx
quality assurance.pptxNishanthiniP2
 
quality assurance.pptx
 quality assurance.pptx quality assurance.pptx
quality assurance.pptxNishanthiniP2
 
IP 2 / UNIT 4 /QUALITY MANAGEMENT SYSTEMS (QMS)
IP 2 / UNIT 4 /QUALITY MANAGEMENT SYSTEMS (QMS)IP 2 / UNIT 4 /QUALITY MANAGEMENT SYSTEMS (QMS)
IP 2 / UNIT 4 /QUALITY MANAGEMENT SYSTEMS (QMS)JAYACHANDRA AKUTHOTA
 
Quality control grp.7 (49-56)
Quality control grp.7  (49-56)Quality control grp.7  (49-56)
Quality control grp.7 (49-56)AkankshaLunge
 
Concept of qa, qc, gmp 112070804010
Concept of qa, qc, gmp  112070804010Concept of qa, qc, gmp  112070804010
Concept of qa, qc, gmp 112070804010Patel Parth
 
2) Total Quality Managment
2) Total Quality Managment2) Total Quality Managment
2) Total Quality ManagmentSangam Kanthale
 
Pharmaceutical validation
Pharmaceutical validationPharmaceutical validation
Pharmaceutical validationMadhavMady3
 
QUALITY BY DESIGN PPT BY GIRIJA
QUALITY BY DESIGN PPT BY GIRIJAQUALITY BY DESIGN PPT BY GIRIJA
QUALITY BY DESIGN PPT BY GIRIJAGirija Dandu
 
Gmp Auditor Training Course
Gmp Auditor   Training CourseGmp Auditor   Training Course
Gmp Auditor Training Coursepiyush64173
 
Quality Management Systems (2).pdf
Quality Management Systems (2).pdfQuality Management Systems (2).pdf
Quality Management Systems (2).pdftejas359590
 

Ähnlich wie Quality & compliance excellence in pharmaceuticals (20)

Basic concepts of QA and QC
Basic concepts of QA and QCBasic concepts of QA and QC
Basic concepts of QA and QC
 
Lecture 2: QA and Qc in Pharma Industry
Lecture 2: QA and Qc in Pharma IndustryLecture 2: QA and Qc in Pharma Industry
Lecture 2: QA and Qc in Pharma Industry
 
Unit-1_QA.pdf
Unit-1_QA.pdfUnit-1_QA.pdf
Unit-1_QA.pdf
 
PharmaceuticalQuality by Design (QbD) An Introduction Process Development a...
PharmaceuticalQuality by Design (QbD)   An Introduction Process Development a...PharmaceuticalQuality by Design (QbD)   An Introduction Process Development a...
PharmaceuticalQuality by Design (QbD) An Introduction Process Development a...
 
GMP documentation
GMP documentationGMP documentation
GMP documentation
 
Quality assurance tools & techniques
Quality assurance tools & techniquesQuality assurance tools & techniques
Quality assurance tools & techniques
 
Quality
QualityQuality
Quality
 
good laboratory practices.pptx
good laboratory practices.pptxgood laboratory practices.pptx
good laboratory practices.pptx
 
Qa tools and techniques
Qa tools and techniquesQa tools and techniques
Qa tools and techniques
 
quality assurance.pptx
quality assurance.pptxquality assurance.pptx
quality assurance.pptx
 
quality assurance.pptx
 quality assurance.pptx quality assurance.pptx
quality assurance.pptx
 
IP 2 / UNIT 4 /QUALITY MANAGEMENT SYSTEMS (QMS)
IP 2 / UNIT 4 /QUALITY MANAGEMENT SYSTEMS (QMS)IP 2 / UNIT 4 /QUALITY MANAGEMENT SYSTEMS (QMS)
IP 2 / UNIT 4 /QUALITY MANAGEMENT SYSTEMS (QMS)
 
Quality control grp.7 (49-56)
Quality control grp.7  (49-56)Quality control grp.7  (49-56)
Quality control grp.7 (49-56)
 
Concept of qa, qc, gmp 112070804010
Concept of qa, qc, gmp  112070804010Concept of qa, qc, gmp  112070804010
Concept of qa, qc, gmp 112070804010
 
2) Total Quality Managment
2) Total Quality Managment2) Total Quality Managment
2) Total Quality Managment
 
Pharmaceutical validation
Pharmaceutical validationPharmaceutical validation
Pharmaceutical validation
 
QUALITY BY DESIGN PPT BY GIRIJA
QUALITY BY DESIGN PPT BY GIRIJAQUALITY BY DESIGN PPT BY GIRIJA
QUALITY BY DESIGN PPT BY GIRIJA
 
Gmp Auditor Training Course
Gmp Auditor   Training CourseGmp Auditor   Training Course
Gmp Auditor Training Course
 
Quality assuarance
Quality assuaranceQuality assuarance
Quality assuarance
 
Quality Management Systems (2).pdf
Quality Management Systems (2).pdfQuality Management Systems (2).pdf
Quality Management Systems (2).pdf
 

Mehr von Anvita Bharati

Formulation and development of antihypertensive immediate release tablets
Formulation and development of antihypertensive immediate release tabletsFormulation and development of antihypertensive immediate release tablets
Formulation and development of antihypertensive immediate release tabletsAnvita Bharati
 
Developing research plan
Developing research planDeveloping research plan
Developing research planAnvita Bharati
 
Theory for gas chromatography
Theory for gas chromatographyTheory for gas chromatography
Theory for gas chromatographyAnvita Bharati
 
Antibody drug conjugates for cancer
Antibody drug conjugates for cancerAntibody drug conjugates for cancer
Antibody drug conjugates for cancerAnvita Bharati
 
Targeted Therapies for Breast Cancer
Targeted Therapies for Breast CancerTargeted Therapies for Breast Cancer
Targeted Therapies for Breast CancerAnvita Bharati
 

Mehr von Anvita Bharati (11)

Formulation and development of antihypertensive immediate release tablets
Formulation and development of antihypertensive immediate release tabletsFormulation and development of antihypertensive immediate release tablets
Formulation and development of antihypertensive immediate release tablets
 
Implants
ImplantsImplants
Implants
 
Developing research plan
Developing research planDeveloping research plan
Developing research plan
 
Theory for gas chromatography
Theory for gas chromatographyTheory for gas chromatography
Theory for gas chromatography
 
Antibody drug conjugates for cancer
Antibody drug conjugates for cancerAntibody drug conjugates for cancer
Antibody drug conjugates for cancer
 
Closures
ClosuresClosures
Closures
 
Prodrug strategy
Prodrug strategyProdrug strategy
Prodrug strategy
 
Degradation kinetics
Degradation kineticsDegradation kinetics
Degradation kinetics
 
Microextraction
MicroextractionMicroextraction
Microextraction
 
Drug targeting
Drug targetingDrug targeting
Drug targeting
 
Targeted Therapies for Breast Cancer
Targeted Therapies for Breast CancerTargeted Therapies for Breast Cancer
Targeted Therapies for Breast Cancer
 

Último

NECROSIS FOR MBBS FIRST YEAR STUDENTS MADE EASY.pptx
NECROSIS FOR MBBS FIRST YEAR STUDENTS MADE EASY.pptxNECROSIS FOR MBBS FIRST YEAR STUDENTS MADE EASY.pptx
NECROSIS FOR MBBS FIRST YEAR STUDENTS MADE EASY.pptxSizan Thapa
 
ANATOMY OF THE CEREBRUM WITH CLINICAL ANATOMY.pptx
ANATOMY OF THE CEREBRUM WITH CLINICAL ANATOMY.pptxANATOMY OF THE CEREBRUM WITH CLINICAL ANATOMY.pptx
ANATOMY OF THE CEREBRUM WITH CLINICAL ANATOMY.pptxsiddharthroy26587
 
(IDE)and(IVD),QMS,21 CFR part820 , 801)
(IDE)and(IVD),QMS,21 CFR part820  , 801)(IDE)and(IVD),QMS,21 CFR part820  , 801)
(IDE)and(IVD),QMS,21 CFR part820 , 801)chahattyagi200
 
Cholesterol Biosynthesis and catabolism for MBBS, Lab. MEd. BDS.pptx
Cholesterol Biosynthesis  and catabolism for MBBS, Lab. MEd. BDS.pptxCholesterol Biosynthesis  and catabolism for MBBS, Lab. MEd. BDS.pptx
Cholesterol Biosynthesis and catabolism for MBBS, Lab. MEd. BDS.pptxRajendra Dev Bhatt
 
Reproductive and Child Health Services ppt.pptx
Reproductive and Child Health Services ppt.pptxReproductive and Child Health Services ppt.pptx
Reproductive and Child Health Services ppt.pptxVeereshDemashetti
 
SMA Implementation science seminar (Day 1).pptx
SMA Implementation science seminar (Day 1).pptxSMA Implementation science seminar (Day 1).pptx
SMA Implementation science seminar (Day 1).pptxAbdirahmanWaseem
 
Explaining "pathology" in digital pathology
Explaining "pathology" in digital pathologyExplaining "pathology" in digital pathology
Explaining "pathology" in digital pathologyYves Sucaet
 
Neutraceuticals, Herb-drug & Herb-food inetractions
Neutraceuticals, Herb-drug & Herb-food inetractionsNeutraceuticals, Herb-drug & Herb-food inetractions
Neutraceuticals, Herb-drug & Herb-food inetractionsPradnya Wadekar
 
Ovarian tumors Lecture notes for MBBS.pptx
Ovarian tumors Lecture notes for MBBS.pptxOvarian tumors Lecture notes for MBBS.pptx
Ovarian tumors Lecture notes for MBBS.pptxSizan Thapa
 
Spinal cord Gross anatomy with Clinical Anatomy.pptx
Spinal cord Gross anatomy with Clinical Anatomy.pptxSpinal cord Gross anatomy with Clinical Anatomy.pptx
Spinal cord Gross anatomy with Clinical Anatomy.pptxsiddharthroy26587
 
airway management recorded for S2.pptx
airway management  recorded  for S2.pptxairway management  recorded  for S2.pptx
airway management recorded for S2.pptxnakera38
 
INTRODUCTION TO THE FORENSIC SCIENCE.ppt
INTRODUCTION TO THE FORENSIC SCIENCE.pptINTRODUCTION TO THE FORENSIC SCIENCE.ppt
INTRODUCTION TO THE FORENSIC SCIENCE.pptKavitha Krishnan
 
Thyroid hormones- synthesis, secretion, functions and disorders
Thyroid hormones- synthesis, secretion, functions and disordersThyroid hormones- synthesis, secretion, functions and disorders
Thyroid hormones- synthesis, secretion, functions and disordersSai Sailesh Kumar Goothy
 
Histology of lymph node(lymph node histology)
Histology of lymph node(lymph node histology)Histology of lymph node(lymph node histology)
Histology of lymph node(lymph node histology)pranavguleria2
 
Problems associated with the production of recombinant protein.pdf
Problems associated with the production of recombinant protein.pdfProblems associated with the production of recombinant protein.pdf
Problems associated with the production of recombinant protein.pdfNetHelix
 
Methicillin-resistant Staphylococcus Aureus (MRSA)
Methicillin-resistant Staphylococcus Aureus (MRSA)Methicillin-resistant Staphylococcus Aureus (MRSA)
Methicillin-resistant Staphylococcus Aureus (MRSA)Ahmad Thanin
 
Ayurveda research in Hypothyroidism, P
Ayurveda  research  in Hypothyroidism, PAyurveda  research  in Hypothyroidism, P
Ayurveda research in Hypothyroidism, PDr.Shalu Jain
 
Basic of Thyroid Hormone:- An In-depth Analysis
Basic of Thyroid Hormone:- An In-depth AnalysisBasic of Thyroid Hormone:- An In-depth Analysis
Basic of Thyroid Hormone:- An In-depth AnalysisAshishMaletha2
 
Neurological Evaluation of Acute Ischemic stroke in Emergency Room
Neurological Evaluation of Acute Ischemic stroke in Emergency RoomNeurological Evaluation of Acute Ischemic stroke in Emergency Room
Neurological Evaluation of Acute Ischemic stroke in Emergency RoomSudhir Kumar
 
clean rooms and its classification .pptx
clean rooms and its classification .pptxclean rooms and its classification .pptx
clean rooms and its classification .pptxushakiranmai4
 

Último (20)

NECROSIS FOR MBBS FIRST YEAR STUDENTS MADE EASY.pptx
NECROSIS FOR MBBS FIRST YEAR STUDENTS MADE EASY.pptxNECROSIS FOR MBBS FIRST YEAR STUDENTS MADE EASY.pptx
NECROSIS FOR MBBS FIRST YEAR STUDENTS MADE EASY.pptx
 
ANATOMY OF THE CEREBRUM WITH CLINICAL ANATOMY.pptx
ANATOMY OF THE CEREBRUM WITH CLINICAL ANATOMY.pptxANATOMY OF THE CEREBRUM WITH CLINICAL ANATOMY.pptx
ANATOMY OF THE CEREBRUM WITH CLINICAL ANATOMY.pptx
 
(IDE)and(IVD),QMS,21 CFR part820 , 801)
(IDE)and(IVD),QMS,21 CFR part820  , 801)(IDE)and(IVD),QMS,21 CFR part820  , 801)
(IDE)and(IVD),QMS,21 CFR part820 , 801)
 
Cholesterol Biosynthesis and catabolism for MBBS, Lab. MEd. BDS.pptx
Cholesterol Biosynthesis  and catabolism for MBBS, Lab. MEd. BDS.pptxCholesterol Biosynthesis  and catabolism for MBBS, Lab. MEd. BDS.pptx
Cholesterol Biosynthesis and catabolism for MBBS, Lab. MEd. BDS.pptx
 
Reproductive and Child Health Services ppt.pptx
Reproductive and Child Health Services ppt.pptxReproductive and Child Health Services ppt.pptx
Reproductive and Child Health Services ppt.pptx
 
SMA Implementation science seminar (Day 1).pptx
SMA Implementation science seminar (Day 1).pptxSMA Implementation science seminar (Day 1).pptx
SMA Implementation science seminar (Day 1).pptx
 
Explaining "pathology" in digital pathology
Explaining "pathology" in digital pathologyExplaining "pathology" in digital pathology
Explaining "pathology" in digital pathology
 
Neutraceuticals, Herb-drug & Herb-food inetractions
Neutraceuticals, Herb-drug & Herb-food inetractionsNeutraceuticals, Herb-drug & Herb-food inetractions
Neutraceuticals, Herb-drug & Herb-food inetractions
 
Ovarian tumors Lecture notes for MBBS.pptx
Ovarian tumors Lecture notes for MBBS.pptxOvarian tumors Lecture notes for MBBS.pptx
Ovarian tumors Lecture notes for MBBS.pptx
 
Spinal cord Gross anatomy with Clinical Anatomy.pptx
Spinal cord Gross anatomy with Clinical Anatomy.pptxSpinal cord Gross anatomy with Clinical Anatomy.pptx
Spinal cord Gross anatomy with Clinical Anatomy.pptx
 
airway management recorded for S2.pptx
airway management  recorded  for S2.pptxairway management  recorded  for S2.pptx
airway management recorded for S2.pptx
 
INTRODUCTION TO THE FORENSIC SCIENCE.ppt
INTRODUCTION TO THE FORENSIC SCIENCE.pptINTRODUCTION TO THE FORENSIC SCIENCE.ppt
INTRODUCTION TO THE FORENSIC SCIENCE.ppt
 
Thyroid hormones- synthesis, secretion, functions and disorders
Thyroid hormones- synthesis, secretion, functions and disordersThyroid hormones- synthesis, secretion, functions and disorders
Thyroid hormones- synthesis, secretion, functions and disorders
 
Histology of lymph node(lymph node histology)
Histology of lymph node(lymph node histology)Histology of lymph node(lymph node histology)
Histology of lymph node(lymph node histology)
 
Problems associated with the production of recombinant protein.pdf
Problems associated with the production of recombinant protein.pdfProblems associated with the production of recombinant protein.pdf
Problems associated with the production of recombinant protein.pdf
 
Methicillin-resistant Staphylococcus Aureus (MRSA)
Methicillin-resistant Staphylococcus Aureus (MRSA)Methicillin-resistant Staphylococcus Aureus (MRSA)
Methicillin-resistant Staphylococcus Aureus (MRSA)
 
Ayurveda research in Hypothyroidism, P
Ayurveda  research  in Hypothyroidism, PAyurveda  research  in Hypothyroidism, P
Ayurveda research in Hypothyroidism, P
 
Basic of Thyroid Hormone:- An In-depth Analysis
Basic of Thyroid Hormone:- An In-depth AnalysisBasic of Thyroid Hormone:- An In-depth Analysis
Basic of Thyroid Hormone:- An In-depth Analysis
 
Neurological Evaluation of Acute Ischemic stroke in Emergency Room
Neurological Evaluation of Acute Ischemic stroke in Emergency RoomNeurological Evaluation of Acute Ischemic stroke in Emergency Room
Neurological Evaluation of Acute Ischemic stroke in Emergency Room
 
clean rooms and its classification .pptx
clean rooms and its classification .pptxclean rooms and its classification .pptx
clean rooms and its classification .pptx
 

Quality & compliance excellence in pharmaceuticals

  • 2. What is Quality  It can be defined in different ways  Conformance to specifications measures how well the product or service meets the targets and tolerances determined by its designers.  Fitness for use focuses on how well the product performs its intended function or use.  Value for price paid is a definition of quality that consumers often use for product or service usefulness.  Support services provided are often how the quality of a product or service is judged.  A psychological criterion is a subjective definition that focuses on the judgmental evaluation of what constitutes product or service quality.
  • 4. Difference between Pharmaceutical Product & Consumer Goods Pharmaceutical Product Consumer Goods Development • 2 – 3 years Payer • Customer Regulation • Low level of regulation Development • 10 – 15 years Payer • Mostly patient Regulation • Highly regulated
  • 5. Sterile Product  These products are by design required to be free from living micro organisms, pyrogens, & unacceptable particulate matter.  Therefore it has more regulations than non sterile product  In addition to non sterile product quality guidelines there are other procedures such as – Sterilization, Aseptic processing and also Premises Regulations, Equipments etc.
  • 6. Guidelines of the Pharmaceutical Quality WHO Guidelines FDA Guidelines ICH Guidelines
  • 8. Facilities & Equipment  Equipment must be located, designed, constructed, adapted, and maintained to suit the operations to be carried out.  Guidelines given by  WHO Volume 2: good manufacturing practices and inspection (Quality Assurance of Pharmaceuticals), 13.1 to 13.13  US FDA: 21 CFR Part 211.63, 211.105, 211. 68, 211.72, 211.182  Schedule M: 11.1 – 11.5
  • 9. Material  The main objective of a pharmaceutical plant is to produce finished products for patients use from a combination of materials (starting and packaging).  Guidelines given by  WHO Volume 2: good manufacturing practices and inspection (Quality Assurance of Pharmaceuticals) 14.1 to 14.46  US FDA: 21 CFR Part 211  Schedule M: 10.1 – 10.10, 13.1 -13.6,
  • 10. Production  Production operations must follow clearly defined procedures in accordance with manufacturing and marketing authorizations, with the objective of obtaining products of the requisite quality.  Guidelines given by  WHO Volume 2: good manufacturing practices and inspection (Quality Assurance of Pharmaceuticals) 16.1 to 16.35  US FDA: 21 CFR Part 211  Schedule M: 8.1, 8.2, 9.1 – 9.5, 10.2, 24.1 – 24.3
  • 11. Packaging & labeling  All operations, including filling and labeling, that a bulk product has to undergo in order to become a finished product.  Labels applied to containers, equipment or premises should be clear, unambiguous and in the company’s agreed format.  Guidelines given by  WHO Volume 2: good manufacturing practices and inspection (Quality Assurance of Pharmaceuticals)  US FDA: 21 CFR Part 211
  • 12. Laboratory Controls  It is concerned with the organizational process and the conditions under which laboratory studies are planned, performed, monitored, recorded, and reported.  Guidelines given by:  FDA: 21 CFR 58  WHO: handbook of GLP
  • 13. Clinical Practices  Various regulations are involved clinical trials involving human subjects. Guidelines include protection of human rights as a subject in clinical trial. It also provides assurance of the safety and efficacy of the newly developed compounds.  Guidelines given by  WHO: Handbook for Good clinical practice  ICH guidelines  Schedule Y
  • 14. General Practices Recently Applied in the Pharmaceutical Industry Quality risk management Quality by design Corrective action and preventive actions Total quality management
  • 15.  The basic meaning focuses on target populations of regulation, the extent to which they comply with regulation, and why they do so. Compliance Fulfillment/ Conformity
  • 16. Compliance encourages- Ethical behavior Fosters the right values Instills a culture of integrity
  • 17. Regulatory Compliance  The regulatory authorities are empowered to issue and enforce regulations for the manufacture of pharmaceutical products .  Individual pharmaceutical companies produce a set of internal guidelines, rules, and policies to implement the regulation imposed by the regulatory authorities.  Regulatory compliance applied to statements
  • 18. Compliance Program to review policies & procedures through which industry complies with the various regulations program to prevent & detect violations of the regulation.
  • 19. Strategies to achieve Compliance 1 • Creating an Environment that Supports Compliance 2 • Making Compliance Part of Everyone's Job. 3 • Empowering the Regulatory Affairs/Quality Assurance Function 4 • Employ the Appropriate Skills to Obtain Cooperation 5 • Educating Other Departments. 6 • Selling the Benefits of Quality and Compliance. 7 • Using Internal Audits Effectively. 8 • Reviewing and Reporting Quality and Compliance Data. 9 • Explaining the Consequences of Noncompliance.
  • 20. Quality Policies  The ISO 9000 requires quality policies to ensure that executive management has established system for quality.  Quality policies define numerous systems as well as executive management’s commitment to quality.
  • 21. Purpose & intent of quality policies  Quality policies help industries to improve their internal compliance & total quality system.  By instituting & adhering to quality policies, management obtains employees commitment to quality system.  The formulation of individual quality policies should include the involved groups, depending on the placement of responsibilities within the individual organization.
  • 22. Format & content of individual quality policies  Executive management will probably determine who writes & edits the individual quality policies.  Policies should contain minimal information on specific procedure & detailed information about structure, responsibility, & review.  Definitions within policies are important to ensure that all parties are speaking the same language & are understanding.  The policy should define the responsibilities of individual department implementing the policy & should ensure that adequate resources & structure exist for successful implementation.
  • 23. Validation  Pharmaceutical validation can be defined as a documented program, which provides a high degree of assurance that a specific process will consistently produce, a product meeting its pre- determined specifications & quality attributes
  • 24. Advantages of validation Reduction of quality costs Process optimization Assurance of quality Safety
  • 25. CAPA – Compliance Tool  CAPA is corrective and preventive action  Corrective action: Action to eliminate the cause of a detected nonconformity or other undesirable situation.  Preventive action: Action to eliminate the cause of a potential nonconformity or other undesirable potential situation.
  • 26. CAPA Process  Identification  Impact / Risk Assessment  Immediate Action  Root Cause Investigation  Conclusion and Quality Decision  Action Plan  Implementation and Follow-up
  • 27. Documentation  Document is a piece of written, typed, printed or electronic matter that provides information or evidence.  In each case, key sections of the documents are examined for compliance.
  • 28. Documentation is essential-  To define the specifications/procedures for all materials and methods of manufacture control.  To ensure that all personnel concerned with manufacturing know what to do and when to do it.  To ensure that authorized persons have all the information necessary to decide whether or not to release a batch of a drug for sale.  To ensure the existence of documented evidence, traceability and to provide records and an audit trail that will permit investigation.  To ensure the availability of the data needed for validation, review and statistical analysis.
  • 29. Categories of documents  Specification (e.g. raw material, packaging material, intermediate, finished product)  Procedures (e.g. SOPs, STPs, process packaging instruction)  Records & Reports  Master Documents (e.g. MPCR, calibration master plan, site master file etc.)  Lists (e.g. certified vendors, employees, equipment, process rooms)
  • 30. Cost of Quality Compliance Cost of Quality Compliance Quality control costs Prevention costs Costs of preparing and implementing a quality plan. Appraisal costs Costs of testing, evaluating, and inspecting quality Quality failure costs Internal failure costs Costs of scrap, rework, and material losses. External failure costs Costs of failure at customer site, including returns, repairs, and recalls.
  • 31. Effects of non compliance  Complaints & adverse effects: Complaints about product is an indicator of the product quality, & also about the expectation of the consumer from the product.  Recall of the product: A distributed product can be called back for various reasons. Manufacturer or FDA officials found out that the product is substandard.
  • 32. Case Study  The U.S. Food and Drug Administration had notified (on 23/1/2014) Ranbaxy Laboratories, Ltd., that it is prohibited from manufacturing and distributing active pharmaceutical ingredients (APIs) from its facility in Toansa, India, for FDA-regulated drug products.  The FDA’s inspection on Jan. 11, 2014, identified significant CGMP violations. These included Toansa staff retesting raw materials, intermediate drug products, and finished API after those items failed analytical testing and specifications, in order to produce acceptable findings, and subsequently not reporting or investigating these failures.
  • 33. Reasons for Non compliance 1. Lack of Regulatory Knowledge  Requirements are too complex to know and understand.  People cannot comply with regulations if they do not understand what is required.
  • 34. 2 Lack of willingness towards compliance  Compliance is too costly  Overly legalistic regulation  Failure to monitor  Deterrence failure.
  • 35. 3. Lack of ability to achieve compliance  Failures of administrative capacity  Desired outcomes cannot be achieved
  • 36. Quality Audit  Auditors are typical part of regulatory compliance for examine the data trail to determine whether company policies and procedures are followed.  It has different categories – 1) Internal audits 2) External audits 3) Regulatory audits
  • 37. Percentage of compliance:  100% compliance: When the auditor is fully satisfied with the compliance by the auditee by conforming that the auditee meets all the requirements specified in the specific clause  100% non compliance: When the auditor finds the requirements of the specific clause in not all complied with by the auditee.  Partial compliance: When the auditor finds that the auditee has not fully compiled but only part compliance is observed.
  • 38. Compliance classifications (according to US FDA)  NAI – (No Action Indication) No objectionable conditions or practices were found during the inspection  VAI – (Voluntary Actions Indicated) Objectionable conditions were found and documented but objectionable conditions do not meet the threshold for regulatory action  OAI – (Official FDA Action Indicated) Regulatory violence is observed
  • 39. Conclusion Quality & safety should be priority of any pharmaceutical industry. Quality can be achieved by the compliance excellence with the regulations. Compliance program should be there to study regulation & to implement them in best manner. It is the responsibility of everyone.
  • 40. Reference:  Bhaskar Mazumder, Sanjib Bhattacharya and Abhishek Yadav, Total Quality Management in Pharmaceuticals: A Review, International Journal of PharmTech Research, Vol.3, No.1, Pg. No. 365-375, Jan-Mar 2011.  Sumit Kumar, Deepika Tanwar, Nageen Arora, The Role of Regulatory GMP Audit in Pharmaceutical Companies, International Journal of Research and Development in Pharmacy and Life Sciences, Vol. 2, No.4, Pg. No. 493-498, June - July, 2013.  Reham M. Haleem, Maissa Y. Salem, Faten A. Fatahallah, Laila E. Abdelfattah, Quality in the Pharmaceutical Industry – A Literature Review, Saudi Pharmaceutical Journal, 2014.  Julie Fishera, Arantza Aldeaa, René Banares-Alcantara, A Compliance Management System for the Pharmaceutical Industry, 18th European Symposium on Computer Aided Process Engineering – ESCAPE 18, 2008.  Achieving Quality and Compliance Excellence in Pharmaceuticals, Editor Madhu Raju Saghee, Business Horizons, 2012.  U.S. Pharmaceuticals, Compliance and Ethics Code of Conduct, Bristol-Myers Squibb Company, January 1, 2009.
  • 41.  Nancy Singer and Richard DeRisio, Optimizing Regulatory Compliance: Nine Strategies for Success, Compliance-Alliance LLC and Kinetic Concepts Inc., Medical Device and Diagnostic Industry, 2005.  Chapter 2 Compliance Failures, Reducing the Risk of Policy Failure: Challenges for Regulatory Compliance, Organization for Economic Co-operation and Development, 2000.  Ms. Marlise Gyger, CAPA (Corrective Actions and Preventive Actions), Quality and GMP, June 2012.  James E. Carter, Quality Policies – Key to GMP compliance, Pharmaceutical Technology, October 1998.  http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm382736.htm  Quality Assurance of Pharmaceuticals, Good Manufacturing Practices & Inspection, World Health Organization, Volume 2, Second Edition, 2007.  Manohar A. Potdar, cGMP for Pharmaceuticals, PharmMed Press, 2012.